Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
7 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Comparison of Outcome Adjudication by Investigators and by a Central End Point Committee in Heart Failure Trials: Experience of the SHIFT Heart Failure Study.
Circ Heart Fail. 2020 Jul;13(7):e006720. doi: 10.1161/CIRCHEARTFAILURE.119.006720. Epub 2020 Jun 25.
Circ Heart Fail. 2020.
PMID: 32580655
Incremental benefit of drug therapies for chronic heart failure with reduced ejection fraction: a network meta-analysis.
Komajda M, Böhm M, Borer JS, Ford I, Tavazzi L, Pannaux M, Swedberg K.
Komajda M, et al. Among authors: pannaux m.
Eur J Heart Fail. 2018 Sep;20(9):1315-1322. doi: 10.1002/ejhf.1234. Epub 2018 Jun 19.
Eur J Heart Fail. 2018.
PMID: 29806165
Free article.
Review.
Item in Clipboard
Effect of ivabradine in patients with heart failure with preserved ejection fraction: the EDIFY randomized placebo-controlled trial.
Komajda M, Isnard R, Cohen-Solal A, Metra M, Pieske B, Ponikowski P, Voors AA, Dominjon F, Henon-Goburdhun C, Pannaux M, Böhm M; prEserveD left ventricular ejectIon fraction chronic heart Failure with ivabradine studY (EDIFY) Investigators.
Komajda M, et al. Among authors: pannaux m.
Eur J Heart Fail. 2017 Nov;19(11):1495-1503. doi: 10.1002/ejhf.876. Epub 2017 Apr 30.
Eur J Heart Fail. 2017.
PMID: 28462519
Free article.
Clinical Trial.
Item in Clipboard
Predictive probability of success using surrogate endpoints.
Saint-Hilary G, Barboux V, Pannaux M, Gasparini M, Robert V, Mastrantonio G.
Saint-Hilary G, et al. Among authors: pannaux m.
Stat Med. 2019 May 10;38(10):1753-1774. doi: 10.1002/sim.8060. Epub 2018 Dec 12.
Stat Med. 2019.
PMID: 30548627
Item in Clipboard
A comparison of estimation methods adjusting for selection bias in adaptive enrichment designs with time-to-event endpoints.
Di Stefano F, Pannaux M, Correges A, Galtier S, Robert V, Saint-Hilary G.
Di Stefano F, et al. Among authors: pannaux m.
Stat Med. 2022 May 10;41(10):1767-1779. doi: 10.1002/sim.9327. Epub 2022 Jan 31.
Stat Med. 2022.
PMID: 35098579
Item in Clipboard
UCART19, a first-in-class allogeneic anti-CD19 chimeric antigen receptor T-cell therapy for adults with relapsed or refractory B-cell acute lymphoblastic leukaemia (CALM): a phase 1, dose-escalation trial.
Benjamin R, Jain N, Maus MV, Boissel N, Graham C, Jozwik A, Yallop D, Konopleva M, Frigault MJ, Teshima T, Kato K, Boucaud F, Balandraud S, Gianella-Borradori A, Binlich F, Marchiq I, Dupouy S, Almena-Carrasco M, Pannaux M, Fouliard S, Brissot E, Mohty M; CALM Study Group.
Benjamin R, et al. Among authors: pannaux m.
Lancet Haematol. 2022 Nov;9(11):e833-e843. doi: 10.1016/S2352-3026(22)00245-9. Epub 2022 Oct 10.
Lancet Haematol. 2022.
PMID: 36228643
Clinical Trial.
Item in Clipboard
Randomized Trial of Macitentan/Tadalafil Single-Tablet Combination Therapy for Pulmonary Arterial Hypertension.
Grünig E, Jansa P, Fan F, Hauser JA, Pannaux M, Morganti A, Rofael H, Chin KM.
Grünig E, et al. Among authors: pannaux m.
J Am Coll Cardiol. 2024 Jan 30;83(4):473-484. doi: 10.1016/j.jacc.2023.10.045.
J Am Coll Cardiol. 2024.
PMID: 38267108
Free article.
Clinical Trial.
Item in Clipboard
Cite
Cite